Impaired activity of the protein MTOR a strain on the heart

A team of researchers, led by Gianluigi Condorelli, at the University of California San Diego, La Jolla, has generated data in mice that suggest that drugs that inhibit the protein MTOR, which are used to treat several forms of cancer, might have adverse effects on heart function in patients with ongoing heart dysfunction.

In the study, it was found that adult mice lacking MTOR in their heart muscle cells developed a fatal heart condition. Disease was associated with accumulation of the protein 4E-BP1, which is an inhibitor of protein generation that is normally held in check by a complex containing MTOR.

Further analysis indicated that in a model of high blood pressure the mice lacking MTOR in their heart muscle cells developed heart failure more quickly than did normal mice. Importantly, deletion of 4E-BP1 under these conditions improved heart function and survival.

Thus, decreased MTOR activity impairs the protective heart response to stress, by enhancing 4E-BP1 activity, providing a potential new therapeutic strategy for improving heart function in patients with and a warning to clinicians using MTOR inhibitors.


Explore further

I-1c gene therapy: Not such a good idea in heart failure?

More information: www.jci.org/articles/view/4300 … 9037a905ddcd3c581e01
Provided by Journal of Clinical Investigation
Citation: Impaired activity of the protein MTOR a strain on the heart (2010, July 19) retrieved 31 October 2020 from https://medicalxpress.com/news/2010-07-impaired-protein-mtor-strain-heart.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
 shares

Feedback to editors

User comments